IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab.
Vergis N, Patel V, Bogdanowicz K, Czyzewska-Khan J, Keshinro R, Fiorentino F, Day E, Middleton P, Atkinson S, Tranah T, Cross M, Babalis D, Foster N, Lord E, Quaglia A, Lloyd J, Goldin R, Rosenberg W, Parker R, Richardson P, Masson S, Whitehouse G, Sieberhagan C, Patch D, Naoumov N, Dhanda A, Forrest E, Thursz M.
Vergis N, et al. Among authors: day e.
Clin Gastroenterol Hepatol. 2024 Aug 23:S1542-3565(24)00759-6. doi: 10.1016/j.cgh.2024.07.025. Online ahead of print.
Clin Gastroenterol Hepatol. 2024.
PMID: 39181422
Free article.